The public, medical community and politicians throughout the world are witnessing a polarization regarding the safety of the human papilloma virus (HPV) vaccine. A historic, global backlash of parents [1], whose teenagers have been injured by the HPV shot, is currently threatening the very root of a multibillion dollar vaccine industry [2]. While families and communities at the grassroots level continue to organize to effect change at the county, state and district levels, those within the ranks of medicine [3] and research [4]
